These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 10198329)

  • 21. Urocortin prevents indomethacin-induced small intestinal lesions in rats through activation of CRF2 receptors.
    Kubo Y; Kumano A; Kamei K; Amagase K; Abe N; Takeuchi K
    Dig Dis Sci; 2010 Jun; 55(6):1570-80. PubMed ID: 19707872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Footshock-induced urinary bladder hypersensitivity: role of spinal corticotropin-releasing factor receptors.
    Robbins MT; Ness TJ
    J Pain; 2008 Nov; 9(11):991-8. PubMed ID: 18632307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of urocortin, corticotropin-releasing factor (CRF) receptor agonist, and astressin, CRF receptor antagonist, on the sleep-wake pattern: analysis by radiotelemetry in conscious rats.
    Uchida M; Suzuki M; Shimizu K
    Biol Pharm Bull; 2007 Oct; 30(10):1895-7. PubMed ID: 17917258
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of central and peripheral urocortin on fed and fasted gastroduodenal motor activity in conscious rats.
    Kihara N; Fujimura M; Yamamoto I; Itoh E; Inui A; Fujimiya M
    Am J Physiol Gastrointest Liver Physiol; 2001 Mar; 280(3):G406-19. PubMed ID: 11171623
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of an agonist, urocortin, and an antagonist, astressin, as radioligands for characterization of corticotropin-releasing factor receptors.
    Perrin MH; Sutton SW; Cervini LA; Rivier JE; Vale WW
    J Pharmacol Exp Ther; 1999 Feb; 288(2):729-34. PubMed ID: 9918582
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fedotozine reversal of peritoneal-irritation-induced ileus in rats: possible peripheral action on sensory afferents.
    Riviere PJ; Pascaud X; Chevalier E; Junien JL
    J Pharmacol Exp Ther; 1994 Sep; 270(3):846-50. PubMed ID: 7932195
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective activation of corticotropin-releasing factor-2 receptors on neurochemically identified neurons in the rat dorsal raphe nucleus reveals dual actions.
    Pernar L; Curtis AL; Vale WW; Rivier JE; Valentino RJ
    J Neurosci; 2004 Feb; 24(6):1305-11. PubMed ID: 14960601
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urocortin promotes the development of vasculitis in a rat model of thromboangiitis obliterans via corticotrophin-releasing factor type 1 receptors.
    Xu Y; Zhang R; Chen J; Zhang Q; Wang J; Hu J; Guan X; Jin L; Fu H; Gui B; Guo Y; Li S
    Br J Pharmacol; 2009 Aug; 157(8):1368-79. PubMed ID: 19572944
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peripheral and central administration of exogenous urocortin 1 disrupts the fasted motility pattern of the small intestine in rats via the corticotrophin releasing factor receptor 2 and a cholinergic mechanism.
    Yin Y; Dong L; Yin D
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e79-87. PubMed ID: 17944898
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urocortins and cholecystokinin-8 act synergistically to increase satiation in lean but not obese mice: involvement of corticotropin-releasing factor receptor-2 pathway.
    Gourcerol G; Wang L; Wang YH; Million M; Taché Y
    Endocrinology; 2007 Dec; 148(12):6115-23. PubMed ID: 17932219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin 1 beta inhibits gastric emptying in rats: mediation through prostaglandin and corticotropin-releasing factor.
    Sütö G; Király A; Taché Y
    Gastroenterology; 1994 Jun; 106(6):1568-75. PubMed ID: 8194703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Corticotropin-releasing factor receptor subtypes mediating nutritional suppression of estrous behavior in Syrian hamsters.
    Seymour PL; Dettloff SL; Jones JE; Wade GN
    Am J Physiol Regul Integr Comp Physiol; 2005 Aug; 289(2):R418-R423. PubMed ID: 15831766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The first extracellular domain of corticotropin releasing factor-R1 contains major binding determinants for urocortin and astressin.
    Perrin MH; Sutton S; Bain DL; Berggren WT; Vale WW
    Endocrinology; 1998 Feb; 139(2):566-70. PubMed ID: 9449626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravenous injection of urocortin 1 induces a CRF2 mediated increase in circulating ghrelin and glucose levels through distinct mechanisms in rats.
    Wang L; Stengel A; Goebel-Stengel M; Shaikh A; Yuan PQ; Taché Y
    Peptides; 2013 Jan; 39():164-70. PubMed ID: 23183626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urocortin reduces food intake and gastric emptying in lean and ob/ob obese mice.
    Asakawa A; Inui A; Ueno N; Makino S; Fujino MA; Kasuga M
    Gastroenterology; 1999 Jun; 116(6):1287-92. PubMed ID: 10348810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potent and long-acting corticotropin releasing factor (CRF) receptor 2 selective peptide competitive antagonists.
    Rivier J; Gulyas J; Kirby D; Low W; Perrin MH; Kunitake K; DiGruccio M; Vaughan J; Reubi JC; Waser B; Koerber SC; Martinez V; Wang L; Taché Y; Vale W
    J Med Chem; 2002 Oct; 45(21):4737-47. PubMed ID: 12361401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential roles of corticotropin-releasing factor receptor subtypes 1 and 2 in opiate withdrawal and in relapse to opiate dependence.
    Lu L; Liu D; Ceng X; Ma L
    Eur J Neurosci; 2000 Dec; 12(12):4398-404. PubMed ID: 11122350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanism of corticotropin-releasing factor type I receptor regulation by nonpeptide antagonists.
    Hoare SR; Sullivan SK; Ling N; Crowe PD; Grigoriadis DE
    Mol Pharmacol; 2003 Mar; 63(3):751-65. PubMed ID: 12606786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vasodilative effects of urocortin II via protein kinase A and a mitogen-activated protein kinase in rat thoracic aorta.
    Kageyama K; Furukawa K; Miki I; Terui K; Motomura S; Suda T
    J Cardiovasc Pharmacol; 2003 Oct; 42(4):561-5. PubMed ID: 14508243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nociceptin/orphanin FQ-induced delay in gastric emptying: role of central corticotropin-releasing factor and glucocorticoid receptors.
    Broccardo M; Scaccianoce S; Del Bianco P; Agostini S; Petrella C; Improta G
    Neurogastroenterol Motil; 2005 Dec; 17(6):871-7. PubMed ID: 16336503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.